Europe — EMA

Paclitax (Paclitaxel)

Paclitaxel, the active ingredient in Paclitax, is a mitotic inhibitor presented as a strength/form for intravenous use. It treats various malignant neoplasms and is administered in oncology settings.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitax, is a mitotic inhibitor presented as a  strength/form for intravenous use. It treats various malignant neoplasms and is administered in oncology settings.

GNH USA supplies Paclitax as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Paclitaxel used for?

Paclitaxel ... .... .... ... ... ... … … … … ... … … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →